History Selegiline



emsam transdermal patch, 6mg/24hr dose


in 1990s, j. alexander bodkin @ mclean hospital, affiliate of harvard medical school, began collaboration somerset develop delivery of selegiline via transdermal patch in order avoid known dietary restrictions of mao inhibitors. somerset obtained fda approval market patch in 2006.








Comments

Popular posts from this blog

Investigation Murder of Brooke Wilberger

Geography St Columb Major

Shri Ram Centre for Performing Arts Shriram Bharatiya Kala Kendra